Sent Home After An Overdose: The Treatment That Should Start Before You Leave The ER

Someone stops breathing. Someone else calls 911. Naloxone goes in, breathing comes back, and a few hours later a nurse hands over a folded sheet of paper with treatment numbers on it. The person walks back out into the same night they came from, holding a list. They call the numbers the next morning and find waiting lists that run two weeks to two months long.

That gap, between surviving the overdose and actually starting treatment, is where an enormous number of people are lost. It does not have to be that way. Medication for opioid use disorder can be started in the emergency department itself, before discharge, by the same clinician who managed the overdose. Plenty of hospitals now do this. Plenty still do not.

Here is what the evidence actually shows, what ER-initiated treatment looks like in practice, and what to ask for if you or someone you love ends up in that room.

Why The Hours After An Overdose Matter So Much

Surviving an overdose is not a return to normal. It is the beginning of the most dangerous stretch a person is likely to face.

Researchers who tracked more than 11,000 people treated for nonfatal opioid overdose in Massachusetts emergency departments found that about 1 in 100 had died within a month and roughly 1 in 20 within a year, with the first 48 hours after discharge carrying the sharpest risk. The authors concluded what front-line clinicians already suspected: anyone who survives an overdose should be treated as high risk and offered medication before they leave.

The same hours cut the other way too. A person who has just been brought back is often more willing to consider treatment than they will be next week, once the fear fades and withdrawal takes over. They are already in a medical building, already being seen by a prescriber. The hardest logistical barriers to treatment have, for a few hours, disappeared.

What Starting Treatment In The ER Actually Means

For most people this means buprenorphine. It is a partial opioid agonist, which in plain terms means it occupies the same receptors that heroin or fentanyl do, but with a ceiling on its effect. It quiets withdrawal and cravings without producing the cycle of highs and crashes. It is not trading one addiction for another, whatever anyone says. It is treating a medical condition with a medicine, in the same way insulin treats diabetes.

Since the federal X-waiver requirement was removed at the end of 2022, any clinician with an appropriate DEA registration can prescribe buprenorphine where state law allows. The emergency physician who reversed the overdose can write the first prescription and give the first dose in the department.

The evidence behind this is unusually clean. In the landmark Yale randomized trial of ED-initiated buprenorphine, 78% of patients who received the medication in the emergency department were engaged in addiction treatment 30 days later, compared with 45% who got a brief intervention and referral and 37% who got referral information alone. They also reported fewer days of illicit opioid use.

Options have widened since. A 2026 trial across 29 US emergency departments compared a seven-day extended-release buprenorphine injection with standard under-the-tongue dosing and found similar treatment engagement at both 7 and 30 days. That matters practically. For someone with nowhere safe to store medication, an injection that covers the first week removes a real obstacle.

Two other points worth knowing. Methadone cannot usually be started and continued from an ER, but federal rules do allow a hospital to give daily doses for up to three days while a place in an opioid treatment program is arranged. Naltrexone, the third approved medication, requires being off opioids for a week or more first, so it is rarely the right choice on the day of an overdose.

Fentanyl Complication Nobody Should Gloss Over

There is a genuine clinical difficulty here, and honest coverage has to name it.

Buprenorphine binds tightly to opioid receptors and pushes other opioids off them. If it is given while a lot of full agonist is still on board, it can trigger sudden, severe withdrawal, an effect known as precipitated withdrawal. Fentanyl makes this harder to predict, because it lingers in body tissue far longer than heroin did, so a person can feel like they are in withdrawal while fentanyl is still circulating.

Clinicians manage this in a few ways: waiting until objective withdrawal signs reach a threshold on a standard scale, using low-dose starts that build up gradually alongside remaining opioids, or using higher initial doses in a monitored setting. The 2026 trial deliberately enrolled patients with only mild withdrawal, which is part of why its results matter.

None of this is a reason to withhold treatment. It is a reason for the timing to be handled by someone who knows what they are doing, and for the patient to be told what to expect.

Why Many Hospitals Still Hand Over A Phone List

The knowledge has been public for a decade. The practice has not caught up, and the reasons are mostly structural rather than medical.

Many emergency physicians finished training with almost no addiction medicine teaching. Emergency departments are built for rapid stabilization, not for the 40 minutes of counselling, education, and follow-up arranging that a good buprenorphine start involves. Hospitals without an addiction consult service, a peer recovery coach, or a named clinic willing to take same-week referrals have nowhere to hand the patient on to. And in some institutions there is still a lingering belief that addiction is a behavioural problem rather than a treatable illness.

“The emergency department visit right after an overdose reversal is the highest-yield chance we get, and we routinely waste it,” says Rab Nawaz Khan, M.D. “We have someone who nearly died, sitting in a medical setting, and we hand them phone numbers instead of medicine.”

“These barriers are real, but hospitals have solved them,” says Dr. Michael DeShields, MD. “The emergency physician does not have to become an addiction specialist. They need a protocol, a pharmacist and nurse who know the pathway, and a clinic on the other end that will actually see the patient this week.”

What To Ask For Before Discharge

If you can advocate for yourself, do. If you cannot, this is what a family member or friend in the room can ask for. Bring someone if you can, because nobody absorbs much information a few hours after an overdose.

• Ask plainly whether buprenorphine can be started today, in the department. The word to use is “started,” not “referred.”
• Ask for a bridge prescription that lasts until the follow-up appointment, so there is no dry gap.
• Ask for the appointment to be booked before you leave, with the date, time, address, and a phone number written down.
• Ask whether there is a peer recovery coach, addiction consult service, or social worker who can come and talk with you.
• Ask for naloxone in hand, not a prescription to fill somewhere later.
• Ask what to do if withdrawal hits hard before the next dose is due, and who to call.
• Tell them everything you take, including benzodiazepines, alcohol, sleep medication, and any prescribed painkillers. Combining opioids with sedatives is a major overdose risk and it changes how treatment is planned.

If the answer to the first question is no, ask why, and ask for the name of a local bridge clinic or telehealth service that can start it within days.

Naloxone Should Go Home With Every Single Survivor

Anyone who has overdosed once is at raised risk of overdosing again, so leaving without naloxone is a missed opportunity in itself.

Naloxone has been available over the counter in the United States since the FDA approved a nonprescription nasal spray in 2023, and it can be bought at pharmacies and many other shops without a prescription, often free through community distribution and syringe service programmes. The CDC’s guidance on carrying and using naloxone is worth reading with whoever you live with, because you cannot use it on yourself. The people around you need to know what it is, where it is kept, and how to use it. Keep it somewhere obvious rather than tucked away in a drawer, and remember that naloxone can wear off before a strong opioid does, so calling 911 is still part of the response.

First Week Home Is The Riskiest

Two things make the days after discharge so dangerous, and both are worth saying out loud.

Tolerance drops fast. After even a short break, whether from a hospital stay, a detox, or a night in a cell, the dose that felt normal before can be fatal. If someone does use, using less than they used to is not caution, it is survival.

And most fatal overdoses happen when nobody else is there. Not using alone, or staying somewhere another person can check on you, is the single practical thing that keeps a bad outcome from becoming a final one. Most US states have Good Samaritan laws that give some protection to people who call for help during an overdose, though the details differ by state.

If The Hospital Will Not Start Treatment

You still have routes, and you do not have to wait for a residential bed to open up.

• Call SAMHSA’s National Helpline, 1-800-662-HELP (4357). It is free, confidential, and answered 24 hours a day in English and Spanish.
• Search the federal treatment locator at FindTreatment.gov for opioid treatment programmes and buprenorphine prescribers near you.
• Ask about telehealth. Buprenorphine can often be started through a video or phone appointment, which removes the transport problem entirely.
• Try a bridge clinic or low-barrier clinic if your area has one. They exist specifically to start medication the same day and hold people until longer-term care is available.
• Primary care counts. A family doctor can prescribe buprenorphine. So can many nurse practitioners and physician assistants, depending on state law.

Treatment programmes that require you to be drug free before they will help are not the only option available, and they are not the standard of care.

What This Costs, And What It Saves

A single overdose response, with an ambulance, an emergency department visit, and sometimes intensive care, costs thousands of dollars. Generic buprenorphine costs very little, and the staff time to start it is modest. Every overdose that does not happen is money not spent, on top of a life not lost. The clinical case and the financial case point the same direction, which is rare enough to be worth noticing.

The woman in the story at the start of this article is not unusual, and that is the point. She was in a building full of people who could have started her treatment, and instead she was given a list. The medicine was on the shelf. The prescriber was in the room. Nothing rare or expensive was needed. That is what makes this kind of death so hard to accept, and also why it is one of the more fixable problems in medicine right now.

Important Note

References

• Weiner SG, Baker O, Bernson D, Schuur JD. One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose. Annals of Emergency Medicine. 2020;75(1):13-17.
• D’Onofrio G, O’Connor PG, Pantalon MV, et al. Emergency Department-Initiated Buprenorphine and Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial. JAMA. 2015;313(16):1636-1644.
• D’Onofrio G, Herring AA, Hawk KF, et al. Emergency Department-Initiated Buprenorphine for Opioid Use Disorder: A Randomized Clinical Trial. JAMA. 2026;335(11):948-960.
• Larochelle MR, Bernson D, Land T, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality. Annals of Internal Medicine. 2018;169(3):137-145.
• Substance Abuse and Mental Health Services Administration. Waiver Elimination (MAT Act).
• Centers for Disease Control and Prevention. Lifesaving Naloxone, Stop Overdose.
• US Food and Drug Administration. FDA Approves First Over-the-Counter Naloxone Nasal Spray. March 2023.